John P. Roberts, MD, FACS

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
John P. Roberts, MD, FACS

Professor, Department of Surgery, and Chief, Division of Transplantation, UCSF

Phone: (415) 353-1888 (appts)
Box 0780, UCSF
San Francisco, CA 94143-0780

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Education

Stanford University, Palo Alto, CA, BS, 1976, Biology
University of California, San Diego, CA, MD, 1980, Medicine
University of Washington, Seattle, Surgery Resident, 1980-83
Cornell University, New York, Research Fellow, 1983-85
University of Washington, Seattle, Surgery Resident, 1985-86
University of Minnesota, Minneapolis, Transplant Fellow, 1986-87


Professional Experience

  • 1988-1993
    University of California San Francisco, Assistant Professor
  • 1993-1997
    University of California San Francisco, Associate Professor
  • 1995-present
    California Pacific Medical Center, San Francisco, Surgical Director, Liver Transplant Department
  • 1997-present
    University of California San Francisco, Professor
  • 1999-present
    University of California San Francisco, Chief, Transplant Service

Honors & Awards

  • 1991
    Chief Resident Teaching Award, Department of Surgery, UCSF
  • 1992
    Chief Resident Teaching Award, Department of Surgery, UCSF

Selected Publications

  1. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016 Jul-Aug; 15(4):545-9.
    View on PubMed
  2. Pomposelli JJ, Goodrich NP, Emond JC, Humar A, Baker TB, Grant DR, Fisher RA, Roberts JP, Olthoff KM, Gillespie BW, Merion RM. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience. Transplantation. 2016 Jul; 100(7):1490-9.
    View on PubMed
  3. Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation. Transplantation. 2016 Jun; 100(6):1244-50.
    View on PubMed
  4. Mehta N, Roberts JP, Yao FY. Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story? Liver Transpl. 2016 May; 22(5):582-4.
    View on PubMed
  5. Cai L, Yeh BM, Westphalen AC, Roberts JP, Wang ZJ. Adult living donor liver imaging. Diagn Interv Radiol. 2016 May-Jun; 22(3):207-14.
    View on PubMed
  6. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault NA, Feng S. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation. Liver Int. 2016 Apr; 36(4):611.
    View on PubMed
  7. Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016 Mar 10; 374(10):940-50.
    View on PubMed
  8. Roberts JP. The Cost of Fairness. Am J Transplant. 2016 Feb; 16(2):385-6.
    View on PubMed
  9. Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl. 2016 Feb; 22(2):178-87.
    View on PubMed
  10. Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY. Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy? Gastroenterology. 2016 Feb; 150(2):533-4.
    View on PubMed
  11. Olmos A, Feiner J, Hirose R, Swain S, Blasi A, Roberts JP, Niemann CU. Impact of a quality improvement project on deceased organ donor management. Prog Transplant. 2015 Dec; 25(4):351-60.
    View on PubMed
  12. Kwong AJ, Lai JC, Dodge JL, Roberts JP. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver Transpl. 2015 Nov; 21(11):1403-9.
    View on PubMed
  13. Roberts JP. Transplantation: Allocation of liver transplants-a road to consensus. Nat Rev Gastroenterol Hepatol. 2015 Nov; 12(11):615-6.
    View on PubMed
  14. Axelrod DA, Vagefi PA, Roberts JP. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg. 2015 Aug; 262(2):224-7.
    View on PubMed
  15. Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, Broglio K, Hirose R, Roberts JP, Malinoski D. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med. 2015 Jul 30; 373(5):405-14.
    View on PubMed
  16. Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant. 2015 Jun; 29(6):506-12.
    View on PubMed
  17. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
    View on PubMed
  18. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault NA, Feng S. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation. Liver Int. 2015 Sep; 35(9):2167-73.
    View on PubMed
  19. Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clin Transplant. 2015 Jan; 29(1):52-9.
    View on PubMed
  20. Roberts JP. Does center-specific reporting limit innovation. Liver Transpl. 2014 Nov; 20 Suppl 2:S42-4.
    View on PubMed

Go to UCSF Profiles, powered by CTSI